chrisvoncsefalvay/vaers-outcomes huggingface dataset:
So Basically right now I am very fatigue, It started out with nasal congestion, sneezing and a little cough, and those things have pretty much subsided and that started around the 22nd and now the only that I am really felling the is the fatigue and that has been going on since Jan 22, 2022
Pain, swelling, purple color at injection site starting 4/5. Injection site itchy starting 4/8. Low grade fever with rash on neck and trunk starting 4/5. Lymph nodes swollen starting 4/7. Felt bad for 4/5 and 4/6. Beginning to feel better 4/8.
respiratory distress; covid test result: Positive; This is a spontaneous report from a contactable consumer. An 83-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 19:00 at single dose for covid-19 immunisation. The patient medical history was not reported. No other vaccine in four weeks. There were other medications in two weeks. No COVID prior vaccination. No Known allergies. The patient experienced respiratory distress on 09Jan2021 12:00. Patient was taken to hospital then released week later and currently readmitted with respiratory distress. Treatment received for the events. Nasal Swab Covid test post vaccination on 11Jan2021: result Positive. Outcome of events as not recovered.  Information on the lot/batch number has been requested.
This spontaneous report was received from an approximately 77 year old female patient regarding herself. There was no pertinent medical history and no drug reactions or allergies. On 28-MAY-2013, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot number, expiry date, dose and route unspecified) in the left arm. There were no concomitant medications. On 29-MAY-2013 (today), the patient awakened with severe pain at the injection site, red swollen arm from elbow to shoulder and discomfort with any movements with her arm. The patient sought medical attention (called the physician). No treatment was given. No lab tests were performed. The patient was not recovered from the events at the time of reporting. The relatedness for all the events was unknown for PNEUMOVAX 23. Additional information has been requested.
Narrative: COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/27, Pfizer, dose #2 09/20 COVID swab, result: detected 09/21 COVID-19 ANTIGEN (BINAX): NOT DETECTED 12/22 SARS-COV-2 Variant Sequencing: pending 12/22 COVID swab, result: detected 12/29 pt cc: congestion, cough, Rhinorrhea, exposure: unknown
This spontaneous report was received from a nurse concerning a patient of unknown age and gender. The patient's historical conditions, concurrent conditions, concomitant therapies or allergies were not reported. On an unspecified date in 2010, at age 15, the patient was vaccinated with the first dose of GARDASIL (laterality, strength, dose, route, frequency, lot number and expiration date were not reported) for prophylaxis. On 02-OCT-2018, the nurse stated that the unspecified patient, currently 23 years old, received the second dose of GARDASIL 9 injection, reported lot number M044717, expiry date 19-JUL-2019, (laterality, strength, dose, route and frequency were not reported) for prophylaxis (Inappropriate schedule of drug administration), (Product use issue), (Product prescribing issue). No adverse effect was reported.
h/a, achiness, 2 days of nausea, loss of appetite, bloating lasting 2 wks; Pt was not seen by MD;
Shortness of breath with very little exertion; Tightness in the chest.; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath with very little exertion) and CHEST DISCOMFORT (Tightness in the chest.) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Overweight, Sleep apnea (Have a CPAC machine.), Irritable bowel syndrome, Hashimoto's disease and Diabetic.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced DYSPNOEA (Shortness of breath with very little exertion) and CHEST DISCOMFORT (Tightness in the chest.). At the time of the report, DYSPNOEA (Shortness of breath with very little exertion) and CHEST DISCOMFORT (Tightness in the chest.) had not resolved.            No Concomitant medications were provided  No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Aug-2021: Follow up information contains no new information
Vaccine was found to be expired as of 8-31-21. Contacted Health facility. They then followed up with Moderna. Received confirmation from Moderna that vaccine given was still considered viable. No adverse outcomes noted.  ESTIMATED DATE OF DELIVERY: 10-2021, NORMAL PREGNANCY
pifzer covid vaccine for age under 4 was administered instead of pfizer 5-11 which was the correct one. no adverse reactions have been reported
booster; blood sugar rose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for Covid-19 immunization; Bnt162b2 (DOSE 2), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; BLOOD GLUCOSE INCREASED (non-serious), outcome "unknown", described as "blood sugar rose". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101741528 US-PFIZER INC-202101741528;US-PFIZER INC-202101742407 same vaccine, AE and different patient
This spontaneous report as received from a nurse refers to a 12 year old patient. No information regarding the patient's medical history, concurrent conditions or concomitant medications was reported. On 14-DEC-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (dose and route of administration were not reported), lot # L007560. No adverse reaction was reported at the time of the report. This is one of several reports received from the same reporter. Additional information has been requested.
extreme abd pain-hosp from 4JAN97 to 6JAN98 upper GI negative;MD thinks caused from typhoid capsules-pt took only 2;
6 hrs p/ 3rd DPT generalized tonic clonic seizure approx. 45 min. assoc. /w fever. Taken to hospital & then to MD for evaluation.
Patient had his 1s Flu and Pediarix #3 and Prevnar #3 and Hib #3 10-4-07 AM and around 6-7 PM grandmother found him warm and had 3-4 seconds of shaking his upper extremities and rolling up his eyes; possible febrile seizure seen in hospital ER sent home.
shortness of breath; chills; flu like symptoms; bodyaches; temperature 99 and was freezing; walking to other room had shortness of breath, is there all the time; had shortness of breath before but now is more severe, shortness of breath really increase; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), CHILLS (chills), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (bodyaches) and CHILLS (temperature 99 and was freezing) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), CHILLS (chills), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (bodyaches), CHILLS (temperature 99 and was freezing), DYSPNOEA (walking to other room had shortness of breath, is there all the time) and DYSPNOEA (had shortness of breath before but now is more severe, shortness of breath really increase). At the time of the report, DYSPNOEA (shortness of breath), CHILLS (chills), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (bodyaches), CHILLS (temperature 99 and was freezing), DYSPNOEA (walking to other room had shortness of breath, is there all the time) and DYSPNOEA (had shortness of breath before but now is more severe, shortness of breath really increase) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.
Round rash the size of a 50 cents coin.  Itchy and red.  The area turns white when I lift my arm.
pain on his lower back; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a male patient of unspecified age received first dose of BNT162B2, via an unspecified route of administration on 05Feb2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient took the 1st dose on 05Feb2021. After taking the 1st dose, he experienced pain on his lower back on Feb2021 and would like to know if he can take ibuprofen. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Intense UTI and urgency to urinate, no control of it. Fatigue/sleeping, brain confusion, aches, headaches everyday, old injuries became active again i.e. my broken hand 7 years ago began hurting and couldn't use it, my knee would not hold me up to stand and kept going out on me (from 2010 broken tibia and torn knee ligaments). Began a sinus infection, cough and eye pain with awful  bouts of constant sneezing. Third  round of antibiotics for the UTI and my bladder is still not right with leakage and urgency. Liver enzymes are high chart.
Diagnosed with covid, positive test result; Fever; Cough; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Diagnosed with covid, positive test result), PYREXIA (Fever) and COUGH (Cough) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included no adverse event.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced COUGH (Cough). On 26-Jan-2021 at 6:00 PM, the patient experienced PYREXIA (Fever). On 27-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Diagnosed with covid, positive test result). On 27-Jan-2021, PYREXIA (Fever) had resolved. On 28-Jan-2021, COUGH (Cough) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (Diagnosed with covid, positive test result) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS CoV2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered SARS-COV-2 TEST POSITIVE (Diagnosed with covid, positive test result) to be not related. No further causality assessments were provided for PYREXIA (Fever) and COUGH (Cough).    Treatment included Tylenol, cough medicine
87 y/o female complaining of a headache. Patient assessed . Alert and oriented. Vitals within normal limits. Patient refused transport to hospital.
He reported headache and dizziness; Congestion; Cough; runny nose; He reported headache and dizziness; This spontaneous report was received from a Company Representative and refers to an 11-year-old male patient.  No information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided.  On 24-OCT-2022, the patient was vaccinated with meningococcal vaccine; tetanus vaccine as prophylaxis; quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, dose description, lot #, expiry date, route of administration were not provided) for human papilloma virus (HPV).   On 25-OCT-2022, the patient experienced headache and dizziness, additionally the patient had a runny nose and congestion that started on the morning of 24-OCT-2022 and developed a slight cough in the afternoon. The runny nose and cough increased and the congestion remained the same. It was reported that the patient had no fever. The outcome of the adverse event with the suspect therapy and the causality assessment were not provided.
Patient began to feel pain in his arm the day after receiving the vaccine. He still feels pain in the arm and has trouble lifting it.
Information has been received from a physician concerning a 13 year old female who was vaccinated with her second 0.5ml dose of varicella virus vaccine live (Oka/Merck) (No lot number was provided). Subsequently 10 days after vaccination, the patient broke out with chicken pox of 80-100 lesions. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint. Additional information has been requested.
After my third vaccine, I experience left shoulder pain, muscular and tendon pain. I went to the doctor because I already had a regular check-up appointment. My pain is one inch below and on the sides where the vaccine was injected. I think it was in the muscular and tendon area where my pain is. I can also say after my second vaccine, I got COVID arm and also had a small TIA but I did not go to the emergency room. To this day, I still have pain to my left shoulder, muscular and tendon. When I over exert myself or lift anything my pain gets worse. The pain increments and I cannot move my left shoulder and arm at all. My doctor told me to wait it out for a few days to see if the pain goes away.
A female patient (age not reported) whose medical history or concomitant medications was unknown had received an intramuscular dose of FLUZONE HD vaccine (lot number and site of administration not reported) on 17 October 2012. On 18 October 2012, i.e. one day post vaccination, the patient experienced violent tremors that were shaking the bed. The lab investigations and corrective treatment were not reported. The patient's outcome was not reported. Documents held by sender:  none.
Patient tested positive for COVID 19 on 2/2/22.  On 2/7/22 presented to Medical Center worsening symptoms of generalized muscle ache, altered mental status and sepsis of unknown origin.  Patient was started on broad spectrum antibiotics with vancomycin and cefepime.  During dialysis he was noted to have right upper extremity weakness and right-sided facial droop.  STAT CT  showed possible subarachnoid hemorrhage.  on 02/9/22 patient had irregular heart rhythm and accelerated junctional rhythm, cardiology was notified, patient developed a wide-complex sinus wave pattern rhythm and lost pulse and suffered cardiac arrest.  ROSC was obtained, arrived in MCC in extremis, right IJ CVL  and right radial arterial lines placed, started on vasopressors, stress dose steroids', vas cath placed, CRRT started.  Shortly after initial of CRRT patient suffered cardiac arrest, ROSC unable to be maintained.
NauseaVomiting @ 10 minutes after after vaccine "sweating". At 1pm  she experienced nausea, flushes, cold sweat. Narrative:
difficulty raising her arm; very sore arm and deltoid; very sore arm and deltoid; This spontaneous report was received from a medical assistant via company representative. The patient was reporting on herself- currently 38-year-old female. The patient's medical history, concomitant medications, concurrent conditions and drug allergies were not reported.  On an unknown date, the patient was vaccinated with the first dose of HPV rl1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (exact dose, route of administration, injection site, lot number and expiration date were not reported) for prophylaxis. On an unknown date in February 2022, the patient was vaccinated with second dose of HPV rl1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (exact dose, route of administration, injection site, lot number and expiration date were not reported) for prophylaxis.   On an unknown date in February 2022, the patient experienced very sore arm and deltoid, and had difficulties with raising her arm. It was unknown if the patient sought medical attention or if the treatment was given for reported adverse events. The outcome of the events was unknown.  The relatedness between the events and HPV rl1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) was unknown.
This spontaneous report received from a consumer via a company representative concerned a female of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was healthy. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) 1 total dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced legs filled with clots, heart with clots, and lungs with clots. On an unspecified date, the patient died from unknown cause of death. It was unknown if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of lungs with clots, filled legs with clots and heart with clots was not reported. This report was serious (Death, and Other Medically Important Condition). Sender's Comments: V0- 20220354771- Covid-19 vaccine ad26.cov2.s  Death, lungs with clots, legs filled with clots and heart with clots. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable. Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH.
no adverse event; HBP called for AE regarding MMR II. Expired MMR II (expiry 08/13/2023) was administered to a patient on 08/17/2023. Patient is not reporting signs/symptoms of adverse effects. Permission to contact HCP was given. No additional AE/no PQC.; This spontaneous report was received from  an other reporter and refers to a patient of unknown age and gender..  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 17-AUG-2023, the patient started therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, 2nd dose, lot #u025199, expiration date: 13-AUG-2023 (Expired vaccine used), albumin status rHA administered for prophylaxis (strength, dose and route of administration were not provided). The patient did not report signs/symptoms of adverse effects. No additional adverse event (AE) was reporter (no adverse event).
Afternoon of vaccine began chilling, body aches, fatigue, sore arm. Temp rose to 103.5. I alternated Tylenol with Motrin. Tylenol did little to decrease this fever, motrin seemed to bring it down for about and hour then would go back up again. Temp stayed between 102 to 103 through Sunday 2/21/21. Temp 99-101 on Monday 2/22/21. Today as I report, temp is 99 and continue to feel very fatigued with no energy and poor appetite.
pain in left arm      lightheadedness  for two days after pain in arm left  fatigue, brain fog, body stiffness lack of motivation thereafter kept the lightheadedness I am normally very healthy and active and my mind is sharp
the patient has been administered dose of vaccine which was improperly stored.; This spontaneous report has been received from a vaccine coordinator who was also a medical assistant concerning a patient of unknown age and gender. The patient's medical history, drug allergies, concurrent conditions and concomitant therapies were not reported.  On 31-MAY-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) with lot number R002510 and expiration date on 25-JAN-2020 (dose, dose number, route of administration and anatomical location were not provided), for prophylaxis.   It was reported that on 19-MAY-2019, 20-MAY-2019 and in 2020 (conflicting information), the vaccine was exposed to a temperature above 9 degrees Celsius: 16.4 degrees Celsius for 5 hours and 30 minutes, and below 2 degrees Celsius: 0 degrees Celsius for 9.8 hours. There was no previous temperature excursion. The call was placed because of a Digital Data logger report.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA004562:
2nd shot was administered with a vial that was past 12 hours after puncture/The patient received 2nd shot with an expired vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd shot was administered with a vial that was past 12 hours after puncture/The patient received 2nd shot with an expired vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd shot was administered with a vial that was past 12 hours after puncture/The patient received 2nd shot with an expired vial). In 2021, EXPIRED PRODUCT ADMINISTERED (2nd shot was administered with a vial that was past 12 hours after puncture/The patient received 2nd shot with an expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.
Fever, lightheadedness, shaky, muscle pain,  Extreme tiredness, headache
Breakthrough case admission after 3 vaccines Moderna 3/22/21 Lot# 008B21A;  Moderna 4/19/21 Lot# 002C21A;  Moderna 1/4/22 Lot# 060H21A
This spontaneous report was received from a pharmacist via a company representative referring to her sister, a 48 year old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. It was reported that the patient was going to start taking an unspecified medication for severe allergies which can suppress one's immune system. On an unknown date, as a part of the therapy with the unspecified allergy medication, the patient received a dose of ZOSTAVAX 0.65 ml (route of administration, lot number and expiration date were not provided) at age 48 years old (inappropriate schedule of drug administration) prior to start taking the unspecified allergy medication as a precaution (product use in unapproved indication). There was no adverse event reported. Additional information has been requested.